Granted Patent
B2
US 8,216,811 · App. 13/041,176 · Granted Jul 10, 2012
Methods for converting glucose to ascorbic acid
Assignee:
Danisco US Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Described herein are novel nucleic acids, proteins and methods that can be used to provide new catalysts with desirable traits for industrial processes. In particular, novel reductases isolated from the environment using PCR methods are described.
Claims (1)
1. A process for converting glucose to ascorbic acid comprising culturing a host cell comprising a nucleotide sequence which encodes a peptide having an amino acid sequence which has at least about 95% sequence identity to an amino acid sequence of SEQ ID NO:8, wherein said conversion of glucose to ascorbic acid is conducted under conditions suitable for the expression of 2,5-diketo-D-gluconic acid reductase.
Assignments (1)
CHANGE OF NAME
Recorded Jun 7, 2012
From: GENENCOR INTERNATIONAL, INC.
To: DANISCO US INC.
Reel/Frame 028340/0840 →